PUS7 and colorectal carcinoma: To further confirm that pseudouridylation of 7SK Ψ250 is the key regulator of PUS7 downstream pathway in CRC, we employed a catalytically inactive RNA-targeting CRISPR-Cas13 system to specifically manipulate pseudouridylation of 7SK.